Atlas Trials

A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice

Clinical trial NCT02616328 · TERMINATED

Trial details

NCT number
NCT02616328
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2017-01-26
Primary completion
2017-12-12
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.